Kanghua Bio
Overview
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China.
Employees550
Market Cap$5.9B
Revenue$1.2B
Listed OnShenzhen Stock Exchange
Ticker300841
CEOMr. Hongbo Wu
HeadquartersChengdu